[AI for ME] L7-3, FDA (or LDA)

3 game changing ways the FDA says AI will transform drug developmentПодробнее

Dr. Scott Gottlieb: The challenge with A.I. tools is getting it regulated by FDA as medical devicesПодробнее

Connected With Latham: Healthcare Tech – How Will the FDA Regulatory Framework Adapt to AI?Подробнее

AI in Diagnostics: Navigating Risks and Regulatory Hurdles in HealthcareПодробнее

Using A.I. to improve delivery of healthcare 'will be real tipping point', says Dr. Scott GottliebПодробнее

Unlocking Success: FDA Regulatory Strategies for AgeTech Devices and AIПодробнее

Viewpoints: FDA Regulatory Considerations on Approvals for Artificial IntelligenceПодробнее

Position talk: AI for Regulatory Science at FDA (Weida Tong)Подробнее

AI and the FDA: Conversation With Robert M. Califf, MD, Commissioner, FDAПодробнее

85 - FDA Guidance on AI/ML ProductsПодробнее

BrainSee AI-Powered Dementia Test Receives FDA ApprovalПодробнее

This new FDA approved medication can improve your vision. #technology #businessПодробнее

FDA's Digital Health Committee Explores Generative AI's Transformative Effects on HealthcareПодробнее

The New Wave of AI in Healthcare: Interview with Brandon D. Gallas, FDAПодробнее

FDA Approval in Machine Learning - RFS AI Journal Club, June 2018Подробнее

Software Thought Leadership Series - FDA REGULATION OF CLINICAL DECISION SUPPORT SOFTWARE AND AI/MLПодробнее

Episode 7 | AI Conversation Series | Where is the FDA on Artificial Intelligence?Подробнее

Boosting FDA Warning Letters Regulatory Analysis with Generative AI.Подробнее